Literature DB >> 28011636

Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1.

Judith Verhelst1,2, Lien Van Hoecke1,2, Jan Spitaels1,2, Dorien De Vlieger1,2, Annasaheb Kolpe1,2, Xavier Saelens3,2.   

Abstract

The antiviral myxovirus resistance protein 1 (MX1) is an interferon-induced GTPase that plays an important role in the defense of mammalian cells against influenza A viruses. Mouse MX1 interacts with the influenza ribonucleoprotein complexes (vRNPs) and can prevent the interaction between polymerase basic 2 (PB2) and the nucleoprotein (NP) of influenza A viruses. However, it is unclear whether mouse MX1 disrupts the PB2-NP interaction in the context of pre-existing vRNPs or prevents the assembly of new vRNP components. Here, we describe a conditionally active mouse MX1 variant that only exerts antiviral activity in the presence of a small molecule drug. Once activated, this MX1 construct phenocopies the antiviral and NP binding activity of wild type MX1. The interaction between PB2 and NP is disrupted within minutes after the addition of the small molecule activator. These findings support a model in which mouse MX1 interacts with the incoming influenza A vRNPs and inhibits their activity by disrupting the PB2-NP interaction.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  GTPase; MX1; antiviral agent; influenza A; influenza virus; inhibition mechanism; interaction; molecular biology; negative-strand RNA virus; ribonucleoprotein; viral replication; virology

Mesh:

Substances:

Year:  2016        PMID: 28011636      PMCID: PMC5313096          DOI: 10.1074/jbc.M116.748806

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein.

Authors:  Judith Verhelst; Dorien De Vlieger; Xavier Saelens
Journal:  J Vis Exp       Date:  2015-04-21       Impact factor: 1.355

2.  Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.

Authors:  Judith Verhelst; Jan Spitaels; Cindy Nürnberger; Dorien De Vlieger; Tine Ysenbaert; Peter Staeheli; Walter Fiers; Xavier Saelens
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

3.  Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly.

Authors:  Judith Verhelst; Eef Parthoens; Bert Schepens; Walter Fiers; Xavier Saelens
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

4.  The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain.

Authors:  Sarah R Edwards; Thomas J Wandless
Journal:  J Biol Chem       Date:  2007-03-09       Impact factor: 5.157

Review 5.  Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier.

Authors:  Benjamin Mänz; Martin Schwemmle; Linda Brunotte
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

6.  A functional GTP-binding motif is necessary for antiviral activity of Mx proteins.

Authors:  F Pitossi; A Blank; A Schröder; A Schwarz; P Hüssi; M Schwemmle; J Pavlovic; P Staeheli
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.

Authors:  Jan Dittmann; Silke Stertz; Daniel Grimm; John Steel; Adolfo García-Sastre; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

8.  Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus.

Authors:  Patricia E Nigg; Jovan Pavlovic
Journal:  J Biol Chem       Date:  2015-10-27       Impact factor: 5.157

9.  Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus.

Authors:  A M Stranden; P Staeheli; J Pavlovic
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

10.  Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA.

Authors:  Patrick S Mitchell; Corinna Patzina; Michael Emerman; Otto Haller; Harmit S Malik; Georg Kochs
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

View more
  1 in total

1.  Mx1 in Hematopoietic Cells Protects against Thogoto Virus Infection.

Authors:  Jan Spitaels; Lien Van Hoecke; Kenny Roose; Georg Kochs; Xavier Saelens
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.